Dialysis Equipment in California

CloudCath is a digital health medical device company that develops remote monitoring solutions for peritoneal dialysis (PD) patients. The company's flagship product, CloudCath Connect™ PD, is an add-on device for PD cyclers that utilizes optical analysis, IoT sensors, machine learning, and cloud computing to measure turbidity in dialysate effluent. By quantifying fluid analysis rather than relying on subjective visual assessment, CloudCath enables early detection of peritonitis and other complications—on average 3.1 days before patient-reported symptoms. Clinical evidence demonstrates a 45% reduction in peritonitis-related hospitalization and 56% reduction in catheter loss. The system seamlessly integrates with major PD cyclers (Baxter and Fresenius), provides real-time notifications to patients and clinicians, and supports continuous home-based monitoring to shift care from in-center facilities. This innovative approach enhances patient outcomes, improves therapy adherence, and reduces the need for emergency interventions in end-stage renal disease management.

AMPARO Medical Technologies is a manufacturer and formulator of medical-grade hydrocolloid adhesives headquartered in Anaheim, California. The company specializes in custom-formulated hydrocolloid products for medical device attachment, wound care, ostomy, catheter securement, negative pressure wound therapy (NPWT), and cosmetic applications including acne patches. All manufacturing is conducted in-house at the Anaheim facility using raw materials sourced from the USA and Europe. The company's hydrocolloid formulations are engineered to provide superior adhesion to moist skin, high absorbency, and non-skin-sensitizing performance—characteristics that have made hydrocolloid the gold standard in wound care and ostomy for over 50 years. Products can be customized with active ingredients for pain relief, drug delivery, and therapeutic applications. AMPARO's Quality Management System is ISO 13485:2016 accredited by BSI, and all formulations are compliant with ISO 10993 biocompatibility standards, EU REACH and RoHS regulations, and California Proposition 65. The company offers master roll manufacturing with configurable performance characteristics (adhesion, absorption, modulus), physical dimensions (width, thickness, single or double-sided), and component selections (polyurethane or polyethylene film carriers; polyester or paper release liners). Services include design development, technical consultation, and 100% product verification testing conducted by the company's in-house testing laboratory.

Diener Precision Pumps (DPP) is a custom gear pump and metering pump manufacturer serving medical, laboratory, diagnostic, and industrial markets. The company designs and manufactures precision pumps engineered in the USA with production in Switzerland (Embrach). Core product lines include gear pumps (Silencer, Optima, Extreme, Multistream series) for high-volume fluid transfer and continuous flow applications; metering/dosing pumps (Precision and Dual-Precision series) for micro-dosing in diagnostic and analytical equipment; and variable dispense pumps (Exacta series) for sensitive medical applications. DPP specializes in custom OEM solutions with minimum order volume of 100 units/year. Medical and laboratory applications include hemodialysis and peritoneal dialysis systems, laboratory and clinical diagnostics equipment, disinfection and sterilization systems for surgical instruments, and medical device fluid handling. All pumps are manufactured to tight tolerances, tested 100% pre-shipment, laser-marked for traceability, and feature advanced drive electronics for responsive flow and pressure control. The company operates an R&D facility in Lodi, California with prototype capabilities delivering samples within 2–15 days, and maintains quality certifications including NSF/ANSI 169 certification for food-service applications.

Outset Medical, Inc. manufactures and distributes the Tablo Hemodialysis System, an integrated medical device designed to simplify acute and home dialysis treatment. The Tablo is a versatile, all-in-one hemodialysis platform engineered to reduce operational complexity, improve clinical outcomes, and lower treatment costs across the care continuum—from intensive care units and acute hospital settings to in-center dialysis programs and home hemodialysis. The system features automated setup and teardown, cloud-based connectivity with two-way wireless data transfer, and seamless electronic medical record (EMR) integration via the Outset Connect analytics platform. Nurses can be trained on Tablo operation in fewer than four hours; the device supports multiple treatment modalities and achieves adequate dialysis clearance at standard treatment frequencies. Clinical evidence demonstrates reduced infection rates, shorter ICU stays, improved patient symptom indices, and enhanced hospital operational efficiency. Outset provides comprehensive support services including clinical training, technical service, and implementation assistance. The company serves nearly 1,000 hospitals and health systems across the United States, targeting acute care hospitals, critical access hospitals, rural health systems, and patients eligible for home hemodialysis. The Tablo holds FDA clearance and is designed for use in acute, ICU, in-center dialysis, home hemodialysis, inpatient rehabilitation, long-term acute care, and skilled nursing facility settings.

Qisda Corporation is a global technology conglomerate founded in 1984, headquartered in Taiwan. The company operates across five major business segments: displays, projectors, medical devices, smart solutions, and networking services. In the medical sector, Qisda has developed a diversified medical fleet (醫療艦隊) encompassing six key domains: medical equipment, medical consumables, hemodialysis, medical imaging, health & wellness devices, and medical services. The company owns two large integrated hospitals and operates as both a medical device manufacturer and healthcare distribution provider. Qisda is recognized as a Thomson Reuters Global Tech 100 leader, an Asia Best Employer, and a Taiwan Top 10 Sustainability Enterprise. In displays, Qisda ranks as the world's second-largest LCD panel manufacturer, serving consumer, commercial, professional, and medical applications. In projectors, the company ranks in the global top three, holding the second-largest market share in DLP projection technology. The medical business serves first-line healthcare users with integrated solutions across hospital infrastructure, clinical diagnostics, renal therapy, imaging systems, consumer health products, and healthcare management services. Smart solutions span six verticals: smart retail, smart healthcare, smart energy, smart manufacturing, smart enterprise, and smart education, emphasizing hardware-software integration and one-stop provisioning. The networking division provides comprehensive broadband services including wired/wireless networks, broadband infrastructure, systems integration, and 5G enterprise private networks. Qisda operates manufacturing facilities and sales offices across 60+ countries with approximately 30,000 employees.